Alkermes Extended Release Technology

This piece highlights Alkermes’ diverse product portfolio and their powerful expertise in the development of innovative patient-inspired solutions. Their products are based on proprietary science and technology that provide unique treatment options for patients with debilitating diseases.

In particular, Alkermes is focused on drug development for central nervous system (CNS) diseases, a therapeutic area where they have a proven track record. Their aim is to develop new medicines that make significant advances for chronic CNS conditions that affect millions of people like schizophrenia, major depressive disorder and multiple sclerosis.